这是一篇来自已证抗体库的有关人类 PRKAR1B的综述，是根据15篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合PRKAR1B 抗体。
PRKAR1B 同义词: PRKAR1

圣克鲁斯生物技术
小鼠 单克隆（G-6）
  • 免疫印迹; 人类; 图 3a
圣克鲁斯生物技术 PRKAR1B抗体（Santa Cruz Biotechnologies, sc-271446)被用于被用于免疫印迹在人类样本上 (图 3a). Cell Death Differ (2021) ncbi
赛默飞世尔
domestic rabbit 多克隆
  • 免疫印迹; 大鼠; 1:1000; 图 s2a
赛默飞世尔 PRKAR1B抗体（Thermo Fisher, PA5-13798)被用于被用于免疫印迹在大鼠样本上浓度为1:1000 (图 s2a). Aging Cell (2020) ncbi
亚诺法生技股份有限公司
小鼠 单克隆（1F8）
  • 免疫组化-石蜡切片; 人类; 1:100; 图 1g
亚诺法生技股份有限公司 PRKAR1B抗体（Abnova, H00005575-M05)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100 (图 1g). Sci Rep (2017) ncbi
赛信通（上海）生物试剂有限公司
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 1:1000; 图 6f
赛信通（上海）生物试剂有限公司 PRKAR1B抗体（Cell Signaling Technology, 9371)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 6f). Commun Biol (2021) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 1:1000; 图 6d
赛信通（上海）生物试剂有限公司 PRKAR1B抗体（Cell Signaling, 9371)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 6d). Commun Biol (2021) ncbi
domestic rabbit 多克隆
  • 流式细胞仪; 小鼠; 1:100; 图 s6-1a
赛信通（上海）生物试剂有限公司 PRKAR1B抗体（Cell Signaling Technology, 9378)被用于被用于流式细胞仪在小鼠样本上浓度为1:100 (图 s6-1a). elife (2021) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:1000; 图 5l
赛信通（上海）生物试剂有限公司 PRKAR1B抗体（CST, 9378S)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 5l). Sci Adv (2020) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:1000; 图 2a
赛信通（上海）生物试剂有限公司 PRKAR1B抗体（Cell Signaling, 9371)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 2a). Oncogene (2019) ncbi
domestic rabbit 多克隆
  • 其他; 人类; 图 4c
赛信通（上海）生物试剂有限公司 PRKAR1B抗体（Cell Signaling, 9371)被用于被用于其他在人类样本上 (图 4c). Cancer Cell (2018) ncbi
domestic rabbit 多克隆
  • reverse phase protein lysate microarray; 人类; 图 st6
赛信通（上海）生物试剂有限公司 PRKAR1B抗体（CST, 9371)被用于被用于reverse phase protein lysate microarray在人类样本上 (图 st6). Cancer Cell (2017) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:1000; 图 4d
赛信通（上海）生物试剂有限公司 PRKAR1B抗体（Cell Signaling, 9378)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 4d). J Cell Sci (2017) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类
赛信通（上海）生物试剂有限公司 PRKAR1B抗体（Cell Signaling Technology, 9371)被用于被用于免疫印迹在人类样本上. Cell Syst (2017) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 1:1000; 图 2
赛信通（上海）生物试剂有限公司 PRKAR1B抗体（Cell Signaling, 9371)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 2). J Pathol (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 大鼠; 1:1000; 图 6
赛信通（上海）生物试剂有限公司 PRKAR1B抗体（Cell Signaling Technology, 9378)被用于被用于免疫印迹在大鼠样本上浓度为1:1000 (图 6). Cell Signal (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 1:1000; 图 5
赛信通（上海）生物试剂有限公司 PRKAR1B抗体（Cell Signaling Technology, 9378)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 5). Cell Rep (2016) ncbi
文章列表
  1. Shang P, Stepicheva N, Teel K, McCauley A, Fitting C, Hose S, et al. βA3/A1-crystallin regulates apical polarity and EGFR endocytosis in retinal pigmented epithelial cells. Commun Biol. 2021;4:850 pubmed 出版商
  2. Zhang M, Ceyhan Y, Kaftanovskaya E, Vasquez J, Vacher J, Knop F, et al. INPP4B protects from metabolic syndrome and associated disorders. Commun Biol. 2021;4:416 pubmed 出版商
  3. Grisan F, Iannucci L, Surdo N, Gerbino A, Zanin S, Di Benedetto G, et al. PKA compartmentalization links cAMP signaling and autophagy. Cell Death Differ. 2021;28:2436-2449 pubmed 出版商
  4. Sun Z, Yao Y, You M, Liu J, Guo W, Qi Z, et al. The kinase PDK1 is critical for promoting T follicular helper cell differentiation. elife. 2021;10: pubmed 出版商
  5. Qin Y, Chen W, Jiang G, Zhou L, Yang X, Li H, et al. Interfering MSN-NONO complex-activated CREB signaling serves as a therapeutic strategy for triple-negative breast cancer. Sci Adv. 2020;6:eaaw9960 pubmed 出版商
  6. Ye J, Yin Y, Liu H, Fang L, Tao X, Wei L, et al. Tau inhibits PKA by nuclear proteasome-dependent PKAR2α elevation with suppressed CREB/GluA1 phosphorylation. Aging Cell. 2020;19:e13055 pubmed 出版商
  7. Zhang M, Suarez E, Vasquez J, Nathanson L, Peterson L, Rajapakshe K, et al. Inositol polyphosphate 4-phosphatase type II regulation of androgen receptor activity. Oncogene. 2019;38:1121-1135 pubmed 出版商
  8. Ng P, Li J, Jeong K, Shao S, Chen H, Tsang Y, et al. Systematic Functional Annotation of Somatic Mutations in Cancer. Cancer Cell. 2018;33:450-462.e10 pubmed 出版商
  9. Cherniack A, Shen H, Walter V, Stewart C, Murray B, Bowlby R, et al. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell. 2017;31:411-423 pubmed 出版商
  10. Weigand I, Ronchi C, Rizk Rabin M, Dalmazi G, Wild V, Bathon K, et al. Differential expression of the protein kinase A subunits in normal adrenal glands and adrenocortical adenomas. Sci Rep. 2017;7:49 pubmed 出版商
  11. Vidal Quadras M, Holst M, Francis M, Larsson E, Hachimi M, Yau W, et al. Endocytic turnover of Rab8 controls cell polarization. J Cell Sci. 2017;130:1147-1157 pubmed 出版商
  12. Hill S, Nesser N, Johnson Camacho K, Jeffress M, Johnson A, Boniface C, et al. Context Specificity in Causal Signaling Networks Revealed by Phosphoprotein Profiling. Cell Syst. 2017;4:73-83.e10 pubmed 出版商
  13. Shen J, Wang R, He Z, Huang H, He X, Zhou J, et al. NMDA receptors participate in the progression of diabetic kidney disease by decreasing Cdc42-GTP activation in podocytes. J Pathol. 2016;240:149-60 pubmed 出版商
  14. Puchert M, Adams V, Linke A, Engele J. Evidence for the involvement of the CXCL12 system in the adaptation of skeletal muscles to physical exercise. Cell Signal. 2016;28:1205-15 pubmed 出版商
  15. Najibi M, Labed S, Visvikis O, IRAZOQUI J. An Evolutionarily Conserved PLC-PKD-TFEB Pathway for Host Defense. Cell Rep. 2016;15:1728-42 pubmed 出版商